There is a resurgence in the need to evaluate the economic burden of prescription drug hospitalizations in the United States. We used the Wisconsin 2014 Hospital Discharge data to examine opioid related hospitalization incidence and costs. Fentanyl, a powerful synthetic opioid, is frequently being used for as an intraoperative agent in anesthesia, and post-operative recovery in hospitals. According to a 2013 study, synthetic Fentanyl is 40 times more potent than heroin and other prescription opioids; the strength of Fentanyl leads to substantial hospitalizations risks.

Nationally, deaths due to opioid overdose have continually increased for the past 15 years . Deaths specifically related to heroin increased more than four-fold between 2002 and 2014. Hospital inpatient discharge data provide information on non-fatal overdoses, but include a significant lag in reporting time. Syndromic ED visit data provide near real-time identification of public health issues and can be leveraged to inform public health actions on the emerging threat of drug overdose.

Objective

Overdoses of heroin and prescription opioids are a growing cause of mortality in the United States. Deaths from opioids have contributed to a rise in the overall mortality rate of middle-aged white males during an era when other demographics are experiencing life expectancy gains. A successful public health intervention to reverse this mortality trend requires a detailed understanding of which populations are most affected and where those populations live.